All News

March 03, 2021

An analysis of data from the Veterans Health Administration is providing insight into the apparent increase in risk of fracture or osteoporosis among older adults with kidney or ureteral stones.

March 02, 2021

Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021.

March 02, 2021

Results of a two-sample Mendelian randomization analysis suggest vitamin D levels were unlikely to have a large effect on a person's risk for developing type 1 diabetes.

March 01, 2021

An AHA study suggests nearly 66% of all COVID-19 hospitalizations could be attributed to the presence of obesity, diabetes, hypertension, or heart failure.

February 27, 2021

An analysis of more than 30k middle-aged adults from a prospective cohort study in Sweden is providing insight into the effects of exercise and other variables on fracture risk in these patients.

February 26, 2021

An analysis of nearly 500 patients hospitalized with COVID-19 from London suggests dysnatremia could help signal which patients were at an increased risk of complications, including death and need for respiratory support.

February 26, 2021

A study of 80 young women is providing clinicians with insight into how total body fat can impact the timing of puberty and levels of pubertal hormones in women.

February 25, 2021

An analysis of data from a 12-week trial in overweight men on testosterone therapy is providing insight into the potential effect of testosterone therapy on vascular health and function.

February 24, 2021

A review of 39 randomized clinical trials examining weight loss interventions is providing clinicians with an overview of engagement rates, mediums used, and effects of digital self-monitoring for weight loss among obese or overweight patients.

February 23, 2021

An analysis of more than 2k patients from within the Look AHEAD study suggests the timing of physical activity could play a role in mitigating cardiovascular risk among men with type 2 diabetes considered overweight or obese.

February 23, 2021

An analysis of data from more than 130 women suggests hypertensive disorders of pregnancy were associated with cardiac remodeling and risk of cardiovascular disease later in life.

February 22, 2021

Our latest case report from Dr. Brady Pregerson features a woman in her 50s presenting with cough, tactile fever, and shortness of breath. Can you determine the correct diagnosis?

February 20, 2021

An analysis of more than 100 patients hospitalized with severe COVID-19 indicates subsequent heart damage was discovered in more than half of these patients in imaging more than a month after discharge.

February 19, 2021

Data from a 20-year follow-up of gender diverse individuals indicate transgender men receiving testosterone therapy were at an 11% increased risk of developing erythrocytosis.

February 18, 2021

An analysis of more than 2k mother-child pairs indicates assessments of maternal cardiovascular health could shed light on the potential for poor cardiovascular health among their children at ages 10-14 years.

February 18, 2021

Our latest case report from Brady Pregerson, MD, features a 62 y/o male with a history of obesity, CAD, anxiety, and COPD presenting with SOB after stating cefalexin. Can you determine the correct diagnosis?

February 17, 2021

This episode of the Endocrine Outlook podcast features an interview on dietary interventions and the role of nutrition in obesity management with Ariana Chao, PhD, CRNP, of the University of Pennsylvania.

February 16, 2021

A survey of providers within the IOF and NOF provides insight into the effects of the COVID-19 pandemic on the diagnosis and treatment of osteoporosis across multiple regions throughout the world.

February 15, 2021

An analysis of data from the UK Biobank cohort is adding to the understanding of HbA1c and neurological health, suggesting patients with prediabetes were at an increased risk of cognitive decline and vascular dementia.

February 12, 2021

An analysis of data from the TRUST trial supports guideline recommendations against levothyroxine for reducing depressive symptoms in older adults with subclinical hypothyroidism.